AstraZeneca and insitro Partner on AI-Driven Drug Discovery
AstraZeneca has collaborated with insitro to use advanced AI systems to develop transformative therapeutics for difficult to treat cardiometabolic diseases.
Digitalization | 16/10/2026 | By News Bureau
Zealand Pharma and Generate Biomedicines Partner on AI Protein Drugs
Zealand Pharma and Generate Biomedicines have entered collaboration and license agreement to develop protein therapeutics engineered with AI for metabolic diseases.
Digitalization | 14/10/2026 | By News Bureau
TDB-DST Backs Peptris with INR 86 Crore for AI Drug Discovery
TDB-DST has partnered with Peptris to provide INR 86 crore in RDI support for AI-driven drug discovery, advancing 4 drug candidates toward clinical development.
Digitalization | 13/10/2026 | By News Bureau
QIAGEN Expands AI Bioinformatics for Research and Drug Discovery
QIAGEN expands AI-powered bioinformatics with IPA Investigator, enabling researchers to ask biological questions in natural language and explore scientific evidence.
Digitalization | 07/10/2026 | By News Bureau
Quotient and Acesion Partner on AI-Enhanced Formulation Development
Quotient Sciences and Acesion Pharma have partnered on AI-enhanced formulation development to accelerate early clinical decisions for atrial fibrillation treatments.
Digitalization | 05/10/2026 | By News Bureau
Robotics to Transform Every Specialty of Medicine, says Dr. Jitendra Singh
Dr. Jitendra Singh highlights robotics, AI and nanoscience as key technologies for precision medicine, with applications ranging from robotic surgery to robotic medicine.
Digitalization | 03/10/2026 | By News Bureau
AbbVie and Iambic Partner on AI-Driven Drug Discovery
AbbVie and Iambic partner to accelerate Artificial Intelligence (AI)-driven small molecule drug discovery across immunology, neuroscience and oncology.
Digitalization | 22/09/2026 | By News Bureau | 127
Tenthpin's AI-IoMT Innovation Hub Debuts in Bengaluru
Switzerland-based Tenthpin has launched Innovation Hub in Bengaluru, establishing a Global Center of Excellence for AI, cloud-driven advanced therapy solutions.
Digitalization | 19/09/2026 | By News Bureau | 150
Nona Biosciences Builds First Language Model for Human HCAbs
Nona Biosciences has unveiled HCAbLM, the world's first Language Model (LM) trained on 31.8M fully human Heavy-Chain-only Antibody sequences.
Digitalization | 17/09/2026 | By News Bureau | 128
Chai Discovery Collaborates with Bristol Myers Squibb to Advance AI-Driven Antibody Discovery
Chai Discovery and Bristol Myers Squibb partner to advance Artificial Intelligence (AI)-driven antibody discovery, leveraging Chai’s molecular folding and design models to identify antibody candidates.
Digitalization | 21/08/2026 | By News Bureau | 148
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy